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Cystic fibrosis (CF) is a genetic life-shortening condition in Caucasians. Despite 
being a multi-organ disease, CF is classically diagnosed by symptoms of acute/chronic 
respiratory disease, with persistent pulmonary infections (Amaral, 2015). CF is caused 
by mutations in the gene encoding cystic fibrosis transmembrane conductance regula-
tor (CFTR) protein. Inheritance of mutant CFTR alleles results in surface liquid deple-
tion and defective mucociliary clearance leading to pulmonary failure. Defects in 
CFTR perturb the regulation of many intracellular signaling pathways including the 
NF-kB pathway causing excessive production of pro-inflammatory mediators. Cur-
rent CF therapies are directed to delay CF lung damage by restoring CFTR function 
and controlling abnormal inflammation. However, only few anti-inflammatory drugs 
are effective for CF treatments (mainly oral corticosteroids and ibuprofen), these drugs 
have limited beneficial effects in presence of considerable side effects. Flavonoids have 
been reported as promising anti-inflammatory drugs and some of them seem to act as 
CFTR direct activators (Amaral, 2015). From this respect, herbal remedies or plant bio-
active molecules may be of great interest. To this aim, we tested the anti-inflammatory 
activity of apolar extracts from the roots of three Peonia species (Paeoniaceae family), 
namely P. rockii P. ostii and P. lactiflora, on CFTR ΔF508/ΔF508 CuFi1 cells and normal 
counterpart. The effects of the extracts on intrinsic as well as TNFα-induced inflam-
mation were evaluated by determining IL-8, IL-6 and RANTES production. Further-
more, to study the direct effect of the extracts on NF-kB activation, Human Embryonic 
Kidney cells were used in transient transfection of NF-kB reporter plasmid and NF-kB 
activity and cytokine productions were also evaluated. Results showed a significant 
anti-inflammatory activity of all three Peonia extracts with the P. lactiflora being the 
most effective. Furthermore, we also tested the anti-inflammatory potential of the pure 
flavonoid naringin in the same model systems. We found that naringin was able to 
reduce cytokine release through inhibiting the key enzymes of the NF-kB and MAPK/
ERK pathways. Interestingly, preliminary results on spray dried pharmaceutical for-
mulations of this molecule, show that naringin co-sprayed with leucine improves 
pharmacological activity of the flavonoid neat raw drug.
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